<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Mena M</submitter><funding>Asociación Española Contra el Cáncer</funding><funding>Instituto de Salud Carlos III</funding><funding>Agency for Administration of University and Research</funding><pagination>3787</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9367257</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(15)</volume><pubmed_abstract>&lt;b>Background&lt;/b>: Tests or test algorithms for diagnosing HPV-driven oral cavity and laryngeal head and neck carcinomas (HNC) have not been yet validated, and the differences among oral cavity and laryngeal sites have not been comprehensively evaluated. We aimed to assess the utility of a diagnostic algorithm for the detection of HPV-driven oral cavity (OCC), oropharyngeal (OPC) and laryngeal (LC) carcinomas using HPV-DNA testing followed by p16&lt;sup>INK4a&lt;/sup> immunohistochemistry, taking E6*I mRNA detection as the reference standard. &lt;b>Methods:&lt;/b> Formalin-fixed paraffin-embedded OCC, OPC, and LC carcinomas were collected from pathology archives in 29 countries. All samples were subjected to histopathological evaluation, DNA quality control, and HPV-DNA detection. All HPV-DNA-positive</pubmed_abstract><journal>Cancers</journal><pubmed_title>Concordance of p16&lt;sup>INK4a&lt;/sup> and E6*I mRNA among HPV-DNA-Positive Oropharyngeal, Laryngeal, and Oral Cavity Carcinomas from the ICO International Study.</pubmed_title><pmcid>PMC9367257</pmcid><funding_grant_id>2017SGR1085</funding_grant_id><funding_grant_id>FIS PI081535, FIS PI1102096, FIS PI1102104, and CIBERESP CB06/02/007</funding_grant_id><pubmed_authors>Lloveras Rubio B</pubmed_authors><pubmed_authors>Mehanna H</pubmed_authors><pubmed_authors>Tous S</pubmed_authors><pubmed_authors>Bosch FX</pubmed_authors><pubmed_authors>On Behalf Of The Ico International Hpv In Head And Neck Cancer Study Group</pubmed_authors><pubmed_authors>Alos L</pubmed_authors><pubmed_authors>Quiros B</pubmed_authors><pubmed_authors>Alejo M</pubmed_authors><pubmed_authors>De Sanjose S</pubmed_authors><pubmed_authors>Tommasino M</pubmed_authors><pubmed_authors>Leon Vintro X</pubmed_authors><pubmed_authors>Morey F</pubmed_authors><pubmed_authors>Pavon MA</pubmed_authors><pubmed_authors>Clavero O</pubmed_authors><pubmed_authors>Munoz N</pubmed_authors><pubmed_authors>Quint W</pubmed_authors><pubmed_authors>Alemany L</pubmed_authors><pubmed_authors>Wang X</pubmed_authors><pubmed_authors>Taberna M</pubmed_authors><pubmed_authors>Pawlita M</pubmed_authors><pubmed_authors>Mena M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Concordance of p16&lt;sup>INK4a&lt;/sup> and E6*I mRNA among HPV-DNA-Positive Oropharyngeal, Laryngeal, and Oral Cavity Carcinomas from the ICO International Study.</name><description>&lt;b>Background&lt;/b>: Tests or test algorithms for diagnosing HPV-driven oral cavity and laryngeal head and neck carcinomas (HNC) have not been yet validated, and the differences among oral cavity and laryngeal sites have not been comprehensively evaluated. We aimed to assess the utility of a diagnostic algorithm for the detection of HPV-driven oral cavity (OCC), oropharyngeal (OPC) and laryngeal (LC) carcinomas using HPV-DNA testing followed by p16&lt;sup>INK4a&lt;/sup> immunohistochemistry, taking E6*I mRNA detection as the reference standard. &lt;b>Methods:&lt;/b> Formalin-fixed paraffin-embedded OCC, OPC, and LC carcinomas were collected from pathology archives in 29 countries. All samples were subjected to histopathological evaluation, DNA quality control, and HPV-DNA detection. All HPV-DNA-positive</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Aug</publication><modification>2025-04-18T18:09:12.894Z</modification><creation>2025-02-19T03:32:20.164Z</creation></dates><accession>S-EPMC9367257</accession><cross_references><pubmed>35954451</pubmed><doi>10.3390/cancers14153787</doi></cross_references></HashMap>